Coway Expands Award-Winning Airmega Line in Canada With Launch of Its Most Compact and Affordable Purifier Yet: The Airmega 50
LOS ANGELES, Aug. 7, 2025 /CNW/ -- Today, Coway, the leading wellness tech company, introduced the Airmega 50 to its Canadian portfolio of award-winning products: its most compact and affordable air purifier to date. Designed to meet rising demand for wellness products in small homes and offices, the Airmega 50 combines award-winning performance with a minimalist, space-saving design that's perfect for desks, dorm rooms, or nurseries.
Demand for small air purifiers is growing as consumers seek personal, portable solutions for cleaner air wherever they live, work, or relax. This is especially crucial during summer allergy and wildfire season, as some parts of Canada are experiencing the worst fires in three decades, and air pollution is soaring. Coway's previous launch in this category, the slightly larger Airmega 100, sold out twice and tripled sales year-over-year in the U.S. The Airmega 50 builds on that momentum with a powerful 360° filtration system, ultra-quiet operation, and budget-friendly $126 CAD price point.
The Airmega 50 delivers robust performance, cleaning areas of up to 500 square feet in one hour. It operates in whisper-quiet Sleep Mode at 18.4 decibels, quieter than a library, making it ideal for bedrooms, video calls, and gaming rooms. Standing just 32.26 centimeters tall, the compact, cylindrical design fits easily on desktops, bedside tables, or shelves. Its sensor detects fine particles including pet dander, bacteria, mold and more, removing 99.999% of ultra-fine particles down to 0.01 micros, smaller than most viruses.
Key features:
Real-Time Air Quality Indicator: A simple, color-coded display keeps users informed of indoor air quality at a glance.
Long-Lasting Filter: Unlike other compact purifiers, the Airmega 50's filter only needs to be replaced once every eight months, saving time and replacement costs.
User-Friendly Design: A filter replacement indicator removes the guesswork for maintenance, while the control panel lock ensures safety around children and pets.
Whisper-Quiet Sleep Mode & Nightlight: Provides gentle illumination that won't disrupt rest, with Sleep Mode turning off all lighting and operating at just 18.4 dB(A).
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
4 minutes ago
- Cision Canada
WuXi Biologics Launches HEK 293 Stable Cell Line Platform WuXia293 Stable for Development and Manufacturing of Difficult-to-Express Molecules
WuXia293 Stable platform demonstrates high titer, human glycosylation and improved product quality by eliminating or significantly alleviating truncation in difficult-to-express molecules. WuXia293 Stable platform maintains stable expression and consistent product quality during long-term cell passages, enabling scalable clinical and commercial manufacturing. SHANGHAI, Aug. 11, 2025 /CNW/ -- WuXi Biologics ( a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the launch of WuXia293 Stable, a new platform designed for the development and manufacturing of innovative, difficult-to-express molecules that are stably expressed in HEK293 cells. The platform, which demonstrates high titers, robust stability and superior quality, significantly enhances the developability and manufacturability of these molecules, offering a highly efficient CMC solution for biologics that are sophisticated in both structure and function. Conventionally, CHO cells have been widely utilized for recombinant protein expression with proven track record of high titers, and good developability and manufacturability. However, complex modalities may not be compatible with CHO expression system, resulting in low titer levels and truncation issues, due to the impact of some CHO-specific host cell proteins (HCPs), that compromise the quality and functionality of the protein products. In contrast, HEK293 cells can eliminate or significantly alleviate truncation issues in expressing complex molecules while maintaining high titer levels. WuXi Biologics developed WuXia293 Stable by leveraging its proprietary HEK293 cell line. Derived from WuXi Biologics' highly-vetted mammalian cell line development platform family WuXia™, WuXia293 Stable demonstrates productivity, quality and stability comparable to WuXia™ while maintaining full compatibility with its process, as shown by its robust growth and balanced metabolism. The platform achieves a fed-batch titer of up to 5.0 g/L for monoclonal antibodies while significantly improving purity. WuXia293 Stable offers flexible scalability in culture scale to meet the diverse needs of various research and pre-clinical development stages. Furthermore, the WuXia293 Stable cell line maintains stable expression and consistent quality during long-term cell passages, enabling scalable clinical and commercial manufacturing at 2000L scale for fed-batch and 1000L scale for perfusion. Moreover, WuXi Biologics offers a comprehensive suite of services for the WuXia293 Stable platform, including cell bank testing and viral clearance validation as part of its one-stop CMC solution. The launch of the WuXia293 Stable platform has further strengthened the service capabilities of WuXi Biologics' WuXia™ platform family. Besides WuXia293 stable, the WuXia™ platform has already derived multiple cell line development platforms, including WuXia ADCC Plus™ and WuXia RidGS™, to address customers' diverse requirements. Dr. Chris Chen, CEO of WuXi Biologics, commented, "We are excited to launch an industry-leading solution that significantly enhances the development of advanced therapeutics. WuXia293 Stable stands as a powerful testament to WuXi Biologics' unwavering commitment to our vision that every biologic can be made and exemplifies our dedication to technological innovation, which enables us to adeptly address the evolving needs of the biopharmaceutical industry. Once again we are reaffirming our promise to enable our clients in accelerating the delivery of innovative biologics to patients worldwide. " About the WuXia™ Cell Line Development Platform Family WuXia™ is a proven, high-yield (up to about 11 g/L) mammalian cell line platform family developed by WuXi Biologics. Accepted by regulatory agencies worldwide, the WuXia™ platform family have generated over 1000 cell lines expressing monoclonal and bispecific antibodies, fusion proteins, enzymes and other recombinant proteins for clinical and commercial manufacturing as of 2024. The WuXia™ platform family include WuXia ADCC Plus™ for developing and manufacturing afucosylated antibodies to elicit an enhanced ADCC response, WuXia RidGS™ for non-antibiotic cell line development, and the latest WuXia293 Stable for expressing difficult-to-express molecules built on HEK293 cell lines. The WuXia™ cell line development platform family continue to expand to cater to the diverse needs of global customers.
Cision Canada
4 minutes ago
- Cision Canada
Zoomlion's Corporate-Named Satellite Enters Orbit, Marking a New Era in Engineering Machinery with Digital, Intelligent, Green, and Global Vision
RIZHAO, China, Aug. 11, 2025 /CNW/ -- Zoomlion Heavy Industry Science & Technology Co., Ltd. ("Zoomlion," has reached a new milestone with the successful entry into orbit of the "Zoomlion" corporate-named satellite, the first of its kind in the global engineering machinery sector. At 00:31 Beijing time, the Geely Constellation Group 04 satellites were launched from the coastal waters near Rizhao, Shandong, China, using the Jielong-3 carrier rocket, with one satellite carrying the Zoomlion name. The "Zoomlion" satellite marks the company's expansion from construction sites on Earth to the vastness of space. It reflects Zoomlion's determination to accelerate digitalization, intelligence, sustainability, and global reach, ensuring service access in even the most challenging environments. As a leader in engineering machinery innovation, Zoomlion drives progress through eight national-level research platforms, over 17,800 patent applications, and more than 570 industry standards. Its groundbreaking products include China's first 3,000-ton crawler crane, the world's longest 101-meter carbon fiber boom pump truck, the first 10,000-ton-meter tower crane, the largest 4,000-ton all-terrain crane, and the highest 82-meter straight-arm aerial work platform. The satellite launch opens new possibilities for global service connectivity, from polar regions and deserts to offshore platforms. It also strengthens the integration of big data, IoT, AI, and satellite communications, supporting a next-generation service ecosystem capable of delivering smarter, faster, and greener solutions worldwide. With its Smart Industrial City as the core, Zoomlion operates 23 world-class intelligent factories, over 10 overseas R&D and manufacturing bases, and more than 30 primary logistics hubs, serving customers in over 200 countries and regions. The company will continue to explore frontier technologies and innovative applications to enhance service efficiency and customer value on a global scale. About Zoomlion Founded in 1992, Zoomlion Heavy Industry Science & Technology Co., Ltd. ( is a leading global manufacturer of high-end equipment, with core businesses in engineering machinery, mining machinery, and agricultural machinery. Its portfolio covers 15 major categories, 75 product series, and 745 product models. Operating in over 200 countries and regions, Zoomlion combines innovation, sustainability, and customer focus to drive progress and create a better future.
Toronto Star
34 minutes ago
- Toronto Star
Air Canada flight attendants picketing at 4 major airports on national day of action
TORONTO - Air Canada flight attendants are expected to picket at airports in four major Canadian cities on Monday in what their union is calling a national day of action. The Canadian Union of Public Employees says demonstrations are expected to take place at Montreal's Pierre Elliott Trudeau International Airport, Toronto Pearson International Airport, Vancouver International Airport and Calgary International Airport, all at 1 p.m. ET.
